FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: iAnthus

  • Home
  •  | 
  • Tag Archives: "iAnthus"

iAnthus Announces Closing of US$35 Million Private Placement of Unsecured Convertible Note Units

iAnthus Announces Closing of US$35 Million Private Placement of Unsecured Convertible Note Units
iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN) (OTCQX: ITHUF), which owns, operates, and partners with best-in-class regulated cannabis operations across the United States, is pleased to announce that it has completed the private placement offering of US$35 million of unsecured convertible notes and corresponding warrants to three investors (the "Offering"). The proceeds from the Offering will be applied to continue the build-out of facilities across the Company's 11-state footprint.
Read more

iAnthus Named to 2019 OTCQX Best 50

iAnthus Named to 2019 OTCQX Best 50
iAnthus Capital Holdings, Inc. ("iAnthus" or "the Company"), (OTCQX: ITHUF, CSE: IAN), which owns, operates, and partners with licensed cannabis operations throughout the United States, is pleased to announce it has been named to the 2019 OTCQX® Best 50, a ranking of top performing companies traded on the OTCQX Best Market last year.
Read more

iAnthus Announces Third Quarter 2018 Financial Results

iAnthus Announces Third Quarter 2018 Financial Results
iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company"), (CSE: IAN, OTCQB: ITHUF), which owns, operates, and partners with licensed cannabis operations throughout the United States, is pleased to announce its financial and operating results for the third quarter of 2018 ("Q3 2018"). All amounts expressed are in USD unless stated otherwise.
Read more

iAnthus and MPX Bioceutical Announce Transformational Combination, Expands U.S. Footprint to 10 States

iAnthus and MPX Bioceutical Announce Transformational Combination, Expands U.S. Footprint to 10 States
NEW YORK and TORONTO, Oct. 18, 2018 /CNW/ - iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company"), (CSE: IAN, OTCQX: ITHUF), and MPX Bioceutical Corporation ("MPX") (CSE: MPX; OTC:MPXEF) announced today that both companies have signed an arrangement agreement (the "Agreement") pursuant to which iAnthus will combine with MPX in an all-stock transaction with offered equity consideration to MPX shareholders valued at $835 million before giving effect to MPX International (defined below) and assuming all of MPX's dilutive securities are exercised prior to the completion of the transaction. The Agreement represents the first public to public merger transaction in U.S. cannabis history.
Read more